BD (Becton, Dickinson and Company) announces the commercial release of the BD AbSeq Immune Discovery Panel (IDP), a pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune markers in a single experiment.
The BD AbSeq IDP leverages next-generation sequencing for single-cell protein expression of its BD AbSeq Assay. The new IDP consists of 30 different specificities targeting most major immune markers, conveniently grouped together in a single tube. The panel helps enable immune cell type identification and the analysis of their activation and suppression status. Further, it allows researchers to include additional immune markers of interest. Its lyophilized format allows for simple reconstitution to stain samples and provides comprehensive performance test data. The IDP is designed to work on the BD Rhapsody Single-Cell Analysis System, alongside RNA and multiplexing assays.